Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Whitten-Bauer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 10, 2009
Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infectionPablo Gastaminza, Christina Whitten-Bauer, Francis V Chisari
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2005
Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsidsStefan F Wieland, Angelina Eustaquio, Christina Whitten-Bauer, et al.
Molecular Cell|June 24, 2006
Native hepatitis B virions and capsids visualized by electron cryomicroscopyKelly A Dryden, Stefan F Wieland, Christina Whitten-Bauer, et al.
Cells|December 8, 2019
The Host Factor Erlin-1 is Required for Efficient Hepatitis C Virus InfectionChristina Whitten-Bauer, Josan Chung, Andoni Gómez-Moreno, et al.
Cell Host & Microbe|October 23, 2012
Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunityMarlène Dreux, Urtzi Garaigorta, Bryan Boyd, et al.
Journal of Virology|March 25, 2011
Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infectionPablo Gastaminza, Suresh M Pitram, Marlene Dreux, et al.
Cytotherapy|April 11, 2018
HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric miceRobert L Kruse, Thomas Shum, Haruko Tashiro, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitroGuofeng Cheng, Ana Montero, Pablo Gastaminza, et al.
Journal of Hepatology|December 15, 2015
In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotidesGaetan Billioud, Robert L Kruse, Melissa Carrillo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|December 10, 2009
Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infectionPablo Gastaminza, Christina Whitten-Bauer, Francis V Chisari
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2005
Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsidsStefan F Wieland, Angelina Eustaquio, Christina Whitten-Bauer, et al.
Molecular Cell|June 24, 2006
Native hepatitis B virions and capsids visualized by electron cryomicroscopyKelly A Dryden, Stefan F Wieland, Christina Whitten-Bauer, et al.
Cells|December 8, 2019
The Host Factor Erlin-1 is Required for Efficient Hepatitis C Virus InfectionChristina Whitten-Bauer, Josan Chung, Andoni Gómez-Moreno, et al.
Cell Host & Microbe|October 23, 2012
Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunityMarlène Dreux, Urtzi Garaigorta, Bryan Boyd, et al.
Journal of Virology|March 25, 2011
Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infectionPablo Gastaminza, Suresh M Pitram, Marlene Dreux, et al.
Cytotherapy|April 11, 2018
HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric miceRobert L Kruse, Thomas Shum, Haruko Tashiro, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitroGuofeng Cheng, Ana Montero, Pablo Gastaminza, et al.
Journal of Hepatology|December 15, 2015
In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotidesGaetan Billioud, Robert L Kruse, Melissa Carrillo, et al.
Pageof 1